Skip to main content

Closed

ERAS: Erasca, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-32.6%

Financially safe

Stretched

Debt / equity0.12×

Interest coverage0.0×

Current ratio9.52×

Erasca, Inc.

ERASNASDAQ Global Select·USD·Closed

Erasca, Inc.

ERASNASDAQ·USD·Closed

$18.15

−2.84%

$18.15

−$0.53 (2.84%)

52W Range

73thpctl

Volume

0.49×avg

Mkt Cap

6.30BUSD

P/E

-19.5TTM

Div Yield

–ann

52W Range

73thpctl

Volume

0.49×avg

Market Cap

6.30BUSD

P/E Ratio

-19.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings